•
Sep 30, 2019

BioLife Q3 2019 Earnings Report

Total Revenue
$6.6M
Previous year: $5.29M
+24.8%
EPS
$0.01
Previous year: $0.05
-80.0%
Gross margin
64%
Adjusted gross margin
69%
Operating loss
-$772K
Gross Profit
$4.52M
Previous year: $3.69M
+22.6%
Cash and Equivalents
$21.2M
Previous year: $32.4M
-34.5%
Free Cash Flow
$1.05M
Previous year: $532K
+97.1%
Total Assets
$83.8M
Previous year: $46.4M
+80.4%

BioLife

BioLife

BioLife Revenue by Segment